Investigator-Initiated Studies (IIS) Program
Who can apply: Open to academic and community-based physicians and researchers worldwide. Proposals must concern AbbVie-associated products or therapeutic areas of interest. Compounds generally must have received regulatory approval for at least one indication in the country of interest, or be on market and available in that country where specified. Proposals are evaluated for scientific merit, alignment with AbbVie research interests, and available funding. Submission does not guarantee approval.
Deadline: Applications are accepted on a rolling submission basis.
